Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
*Lactobacillus oris* is a species of Gram-positive, non-spore-forming lactic acid bacteria naturally found in the human oral cavity, breast milk, and gastrointestinal tract. It is being investigated as a potential probiotic for various health applications. Research indicates that specific strains of *L. oris* possess lipid-lowering properties, potentially reducing cholesterol levels by inhibiting 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) and modulating the FXR-FGF15 signaling pathway. It has also shown promise in improving non-alcoholic fatty liver disease (NAFLD) and enhancing intestinal barrier function through the activation of the pregnane X receptor (PXR). In the context of oral health, *L. oris* exhibits antimicrobial activity against pathogens like *Streptococcus mutans* and *Porphyromonas gingivalis*. While primarily considered a commensal or beneficial organism, some studies have noted its ability to aggregate platelets, suggesting a potential role in the progression of infective endocarditis in susceptible individuals.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lactobacillus oris.